REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patients
Sign Up to like & getrecommendations! Published in 2017 at "Heliyon"
DOI: 10.1016/j.heliyon.2017.e00452
Abstract: Background Reducing the dose of biological therapy (BT) when patients with immune-mediated arthritis achieve a sustained therapeutic goal may help to decrease costs for national health services and reduce the risk of serious infection. However,… read more here.
Keywords: biological therapy; reducing dose; rheumatoid arthritis; spondyloarthritis ... See more keywords